Goserelin

Common brands: Zoladex, Femara, Letrozole, Casodex, Xgeva

Top reporter: Tersera Therapeutics Llc

Aromatase Inhibitor [EPC]Androgen Receptor Inhibitor [EPC]Kinase Inhibitor [EPC]Corticosteroid [EPC]Microtubule Inhibitor [EPC]
13,080
Total Reports
6,297
Serious Reports
2,389
Death Reports
30
Reported Reactions
Death Report Ratio: High (18.26%)

Patient Demographics

Male
5,368
Female
4,439

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Goserelin.

# Reaction Reports % of Total
1 DEATH 1,579
11.2%
2 MALIGNANT NEOPLASM PROGRESSION 1,314
9.3%
3 FATIGUE 862
6.1%
4 METASTASES TO BONE 686
4.8%
5 NEUTROPENIA 637
4.5%
6 NAUSEA 571
4.0%
7 HOT FLUSH 514
3.6%
8 ASTHENIA 503
3.6%
9 DIARRHOEA 476
3.4%
10 PAIN 471
3.3%
11 OFF LABEL USE 460
3.2%
12 DYSPNOEA 439
3.1%
13 METASTASES TO LIVER 434
3.1%
14 ARTHRALGIA 424
3.0%
15 HEADACHE 395
2.8%
16 ANAEMIA 378
2.7%
17 DRUG INEFFECTIVE 354
2.5%
18 DIZZINESS 320
2.3%
19 DISEASE PROGRESSION 317
2.2%
20 VOMITING 305
2.2%
21 MALAISE 295
2.1%
22 BACK PAIN 292
2.1%
23 PYREXIA 288
2.0%
24 DECREASED APPETITE 286
2.0%
25 PROSTATIC SPECIFIC ANTIGEN INCREASED 279
2.0%
26 BREAST CANCER METASTATIC 259
1.8%
27 WEIGHT DECREASED 258
1.8%
28 WHITE BLOOD CELL COUNT DECREASED 255
1.8%
29 FALL 253
1.8%
30 PNEUMONIA 250
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.